These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy. Gurnari C; Voso MT; Girardi K; Mastronuzzi A; Strocchio L Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440683 [TBL] [Abstract][Full Text] [Related]
25. [Interpretation of the expert Chinese guideline for diagnosis and treatment of acute promyelocytic leukemia (2014)]. Shen Z Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):478. PubMed ID: 24857228 [No Abstract] [Full Text] [Related]
30. Treatment of acute promyelocytic leukemia for older patients. Prebet T; Gore SD J Natl Compr Canc Netw; 2011 Mar; 9(3):337-42. PubMed ID: 21393443 [TBL] [Abstract][Full Text] [Related]
31. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-2. Acute promyelocytic leukemia (APL). Fujita H; Ishikawa Y; Yokoyama Y Int J Hematol; 2020 Jun; 111(6):747-760. PubMed ID: 32347422 [No Abstract] [Full Text] [Related]
32. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience. Pulsoni A; Pagano L; Lo Coco F; Avvisati G; Mele L; Di Bona E; Invernizzi R; Leoni F; Marmont F; Mele A; Melillo L; Nosari AM; Pogliani EM; Vignetti M; Visani G; Zagonel V; Leone G; Mandelli F Blood; 2002 Sep; 100(6):1972-6. PubMed ID: 12200354 [TBL] [Abstract][Full Text] [Related]
33. [Microgranular-type acute promyelocytic leukemia with weak myeloperoxidase staining: difficulty of morphological diagnosis]. Matsuda H; Misawa K; Ochiai T; Fujioka I; Iwasaki H; Iwao N; Koike M; Komatsu N Rinsho Ketsueki; 2020; 61(10):1511-1513. PubMed ID: 33162450 [TBL] [Abstract][Full Text] [Related]
34. Treatment of acute promyelocytic leukemia. Arlin ZA Blood; 1992 Sep; 80(5):1365-6. PubMed ID: 1472246 [No Abstract] [Full Text] [Related]
35. Quality of life with treated acute promyelocytic leukaemia. Rahman A Lancet Oncol; 2014 Nov; 15(12):e533. PubMed ID: 25602107 [No Abstract] [Full Text] [Related]
36. Acute promyelocytic leukemia: recent advances in diagnosis and management. Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690 [TBL] [Abstract][Full Text] [Related]
37. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database. Guru Murthy GS; Szabo A; Michaelis L; Carlson KS; Runaas L; Abedin S; Atallah E J Natl Compr Canc Netw; 2020 Feb; 18(2):169-175. PubMed ID: 32023530 [TBL] [Abstract][Full Text] [Related]
38. High-risk acute promyelocytic leukemia with early differentiation syndrome: a therapeutic dilemma. Malato A; Santoro A; Felice R; Magrin S; Turri D; Bica MG; Salemi D; Fabbiano F Acta Haematol; 2012; 127(1):60-2. PubMed ID: 22094378 [No Abstract] [Full Text] [Related]
39. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option. Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357 [TBL] [Abstract][Full Text] [Related]
40. Coexistence of Acute Promyelocytic Leukemia and Primary Plasma Cell Leukemia: Careful Consideration in Diagnosis. Park JH; Choi HW; Shin MG Ann Lab Med; 2022 Mar; 42(2):278-281. PubMed ID: 34635620 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]